HYPERION DEFI INC

HYPDNASDAQ

🏆 #3493 by market capEarnings Aug 12US Equity

$2.64▲ $0.03 (+1.15%)

🌙 After hours$2.68▲ 1.52%Regular close · extended-hours price shown

1h—

24h▲ 1.1%

7d▼ 3.6%

14d▲ 12.8%

30d▼ 11.1%

1y▼ 63.2%

🏦Market Cap

$40M

Small Cap

📈Revenue Growth (YoY)

+1455.1%

High Growth

📊Gross Margin

70.9%

High

💵FCF Margin

—

⚖️P/S Ratio

38.4x

Expensive

Otter Score

Weak

Trading Snapshot

Day Range: $2.60 – $2.68
52-Week Range: $2.34 – $15.00
Volume: $3.10B
Avg Volume: $2.86B
Shares Outstanding: 15.2M
Next Earnings: Oct 21, 2026

Fundamentals Snapshot

Annual Revenue: $813,455
Last Q Revenue: $244,271
P/E Ratio: —
P/S Ratio: 38.4x
EPS (TTM): $-3.92
Dividend Yield: —

Why Investors Own HYPD

✓High-growth profile — revenue up -4.2% YoY with expanding US Equity exposure.
✓Healthy economics — 41% gross margin and 10% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$813,455▼ −4.8% YoY

Gross Margin (TTM)

40.6%▲ +4.4% YoY

Operating Income (TTM)

$244,037▼ −4.8% YoY

Free Cash Flow (TTM)

$82,159▼ −4.8% YoY

About HYPERION DEFI INC

Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.

🦦